Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iñiguez-Ariza NM, Montori VM, Stan MN.
Thyroid. 2020 Mar;30(3):357-364. doi: 10.1089/thy.2019.0132. Epub 2020 Feb 26.
PMID:31973681
Polyaminoglycoside-mediated cell reprogramming system for the treatment of diabetes mellitus.
Pan Y, Shao M, Li P, Xu C, Nie J, Zhang K, Wu S, Sui D, Xu FJ.
J Control Release. 2022 Mar;343:420-433. doi: 10.1016/j.jconrel.2022.01.041. Epub 2022 Jan 29.
PMID:35101476
Human health effects from chronic arsenic poisoning--a review.
Kapaj S, Peterson H, Liber K, Bhattacharya P.
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41(10):2399-428. doi: 10.1080/10934520600873571.
PMID:17018421
Hollow fiber-combined glucose-responsive gel technology as an in vivo electronics-free insulin delivery system.
Matsumoto A, Kuwata H, Kimura S, Matsumoto H, Ochi K, Moro-Oka Y, Watanabe A, Yamada H, Ishii H, Miyazawa T, Chen S, Baba T, Yoshida H, Nakamura T, Inoue H, Ogawa Y, Tanaka M, Miyahara Y, Suganami T.
Commun Biol. 2020 Jun 17;3(1):313. doi: 10.1038/s42003-020-1026-x.
PMID:32555343
Clinical Analysis of the Renal Protective Effect of GLP-1 on Diabetic Patients Based on Edge Detection.
Wang J, Wang Y, Pang P, Jia X, Yan X, Lv Z.
J Healthc Eng. 2022 Mar 22;2022:6504006. doi: 10.1155/2022/6504006. eCollection 2022.
PMID:35360475
Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe.
Janez A, Battelino T, Klupa T, Kocsis G, Kuricová M, Lalić N, Stoian AP, Prázný M, Rahelić D, Šoupal J, Tankova T, Zelinska N.
Diabetes Ther. 2021 Dec;12(12):3107-3135. doi: 10.1007/s13300-021-01160-5. Epub 2021 Oct 25.